Some pathways that the identified targets enriched were directly related to the disease NAFLD, including the NAFLD pathway, type II diabetes mellitus, insulin resistance, insulin signaling pathway, glucagon signaling pathway, regulation of lipolysis in adipocytes, and other signaling pathways like the AMPK and mTOR signaling pathways. This evidence concerns the gene GCG and metabolic dysfunction-associated steatotic liver disease.